by Fecal calprotectin test is a non-invasive laboratory test used to detect levels of calprotectin protein in the stool sample. Calprotectin is a calcium-binding protein found predominantly in the cytosol of neutrophil granulocytes. Elevated levels of calprotectin in the stool is indicative of inflammatory conditions in the gastrointestinal tract such as inflammatory bowel disease (IBD). Fecal calprotectin test helps in differentiating between inflammatory and irritable bowel diseases as well as determines the severity of intestinal inflammation and monitors disease activity and treatment responses in patients diagnosed with IBD. With the increasing prevalence of IBD worldwide, fecal calprotectin testing has gained immense popularity as it allows non-invasive monitoring of intestinal inflammation.
The global Fecal Calprotectin Test Market is estimated to be valued at US$ 140.6 Million in 2023 and is expected to exhibit a CAGR Of 3.9% over the forecast period 2023 To 2030, as highlighted in a new report published by Coherent Market Insights.
Market Dynamics:
Increasing prevalence of inflammatory bowel diseases: According to the estimates by Crohn’s and Colitis foundation, approximately 3 million people in the U.S. have IBD, with approximately 70,000 new cases are diagnosed each year. Globally, approximately 2.5 to 3 million new cases of IBD are diagnosed each year. Fecal calprotectin test plays a vital role in management of inflammatory bowel disease by aiding in diagnosis and monitoring disease progression and treatment responses.
Furthermore, increasing awareness regarding clinical utility of fecal calprotectin testing along with technological advancements leading to development of improved rapid testing kits will also contribute towards market growth over the forecast period.
Segment Analysis
The global fecal calprotectin test market is segmented based on product type, sample type, technology, end-user, and region. Based on product type, the stool collection kit segment is expected to dominate the market during the forecast period. The stool collection kit makes sample collection easy for individuals and helps in proper transportation of stool samples to the laboratory for testing. Based on sample type, the stool segment will continue to hold a major market share owing to the non-invasive nature of stool sampling.
PEST Analysis
Political: Healthcare reforms in various countries are promoting preventive healthcare measures. This is expected to drive the adoption of fecal calprotectin tests for early detection of inflammatory bowel diseases.
Economic: Rising healthcare spending capability and growing awareness about digestive disorders are fueling the market growth. However, the high cost of automated analyzers limits their adoption in resource poor settings.
Social: Growing focus on maintaining well-being and healthy lifestyle has increased the social acceptance of tests like fecal calprotectin that help detect gastrointestinal issues.
Technological: Automated analyzers offer accurate, faster results compared to manual tests. Companies are also developing home test kits to make testing more convenient.
Key Takeaways
The global fecal calprotectin test market is expected to witness high growth owing to the rising prevalence of inflammatory bowel diseases, growing focus on preventive healthcare, and technological advancements. The global Fecal Calprotectin Test Market is estimated to be valued at US$ 140.6 million in 2024 and is expected to exhibit a CAGR of 3.9% over the forecast period 2023 to 2030.
Regional analysis
North America currently dominates the market due to favorable reimbursement policies and increasing awareness about fecal calprotectin testing. Europe is also a major market supported by technological advancements in diagnostic techniques.
Key players operating in the fecal calprotectin test market are BÜHLMANN Laboratories, Aeoon, Fujirebio Europe, Alfa Scientific Designs, Octopus Evolution, and others. BÜHLMANN Laboratories offers the largest product portfolio of calprotectin tests and leads the market.
Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
Money Singh is a seasoned content writer with over four years of experience in the market research sector. Her expertise spans various industries, including food and beverages, biotechnology, chemical and materials, defense and aerospace, consumer goods, etc.
